Ojemann Cortical Stimulator
510(k) K924226
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK924226 | Date21 Apr 1993 | StatusActive |
Recalls
-
- Terminated Z-1030-2013
If the headphone jack is in use during a surgical procedure with the OCS2 and a non-intended voltage (such as static electricity) comes in contact with the outer case of the unit, that voltage could be transmitted to the patient and could be a potential source of injury.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GYC
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.1310
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Ojemann Cortical Stimulator is a cortical electrode device classified under the Neurology specialty. It is a Class 2 medical device with product code GYC and regulation number 882.1310.
The device received FDA 510(k) clearance (K924226) on April 21, 1993, following a traditional review process. It was determined to be substantially equivalent to a predicate device. The stimulator is supplied as a portable system for use in neurological applications.
Other devices from Radionics, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Ojemann Cortical Stimulator used for?
The Ojemann Cortical Stimulator is a cortical electrode device intended for neurological applications, as indicated by its classification under the Neurology specialty and its FDA 510(k) clearance for use as a portable system in such settings.
How is the Ojemann Cortical Stimulator supplied and is it reusable?
The device is supplied as a portable system for use in neurological applications; however, the provided data does not specify whether it is single-use or reusable, so reuse status cannot be determined from the available information.
What regulatory pathway was used for the Ojemann Cortical Stimulator?
The Ojemann Cortical Stimulator received FDA 510(k) clearance (K924226) on April 21, 1993, through a traditional review process, and was found to be substantially equivalent to a predicate device.